MicroRNAs and cancer


MicroRNAs are a type of small non-coding RNA molecule that performs a vital role in post-transcriptional gene regulation. Since miRNAs were first identified in 1993, a number of studies have demonstrated that they act as tumor suppressors or oncogenes in human cancer, including colorectal, lung, brain, breast and liver cancer, and leukemia. Studies have previously revealed that miRNA profiling is important for the diagnosis and prognosis of patients with cancer, while certain miRNAs possess the potential to be used as diagnostic and prognostic biomarkers or therapeutic targets in cancer. Studies review and examines the roles of miRNAs in prognosis, cancer diagnosis and treatment, discusses the probable therapeutic modality of misusing miRNAs.





 


    Related Conference of MicroRNAs and cancer

    December 14-15, 2023

    5th International Conference on Oncology and Cancer

    Rome, Italy
    February 22-23, 2024

    14th World Congress on Breast Cancer

    Zurich, Switzerland
    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    March 21-22, 2024

    8th Global Meeting on Oncology and Radiology

    Paris, France
    April 18-19, 2024

    24th World Congress on Cancer and Diagnostics

    Dubai, UAE

    MicroRNAs and cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in